Normal view MARC view ISBD view

A study on the public health and socioeconomic impact : of substandard and falsified medical products

Contributor(s): World Health Organization
Material type: materialTypeLabelBookPublisher: Geneva : World Health Organization, 2017Description: vii, 67 p. ill ISBN: 9789241513432 Subject(s): Public Health | Fraud | Drug and Narcotic ControlNLM classification: WA 31 2017ST Summary: The presence of substandard and falsified medical products in countries and their use by patients threatens to undermine progress towards meeting the Sustainable Development Goals. Such products may be of poor quality, unsafe or ineffective, threatening the health of those that take them. The problem of substandard and falsified medical products continues to increase, as globalized manufacturing and distribution systems grow ever more complex. That complexity heightens the risk that production errors will occur, or that medicines will degrade between factory and consumer. Increasing demand for medicines, vaccines and other medical products in almost every country, in addition to poor supply-chain management and the growth of e-commerce also creates opportunities for falsified medicines to be introduced into the supply chain.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current library Location Collection Call number Status Date due Barcode
Books Books WHO HQ
PERM-COLL DC-HQ WA 31 2017ST (Browse shelf) Not For Loan 00083478

Licence: CC BY-NC-SA 3.0 IGO

The presence of substandard and falsified medical products in countries and their use by patients threatens to undermine progress towards meeting the Sustainable Development Goals. Such products may be of poor quality, unsafe or ineffective, threatening the health of those that take them. The problem of substandard and falsified medical products continues to increase, as globalized manufacturing and distribution systems grow ever more complex. That complexity heightens the risk that production errors will occur, or that medicines will degrade between factory and consumer. Increasing demand for medicines, vaccines and other medical products in almost every country, in addition to poor supply-chain management and the growth of e-commerce also creates opportunities for falsified medicines to be introduced into the supply chain.

eng.

WHODOC

WHO monograph

WHO/EMP/RHT/2017.02

There are no comments for this item.

Log in to your account to post a comment.